MétaCan
Menu
← Back to cohort

The value of personalizing medicine: Medical oncologists’ and patients’ perspectives on genomic testing of breast tumors in chemotherapy treatment decisions.

2012· article· en· W2595581805 on OpenAlexaffabout
Maureen Trudeau, Yvonne Bombard, Linda Rozmovits, Natasha B. Leighl, Ken Deal, Deborah A. Marshall

Bibliographic record

VenueJournal of Clinical Oncology · 2012
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversity of CalgaryMcMaster UniversityPrincess Margaret Cancer CentreHealth Sciences CentreSunnybrook Health Science Centre
Fundersnot available
KeywordsMedicineBreast cancerFamily medicineQualitative researchPersonalized medicineOncologyAdjuvant chemotherapyTest (biology)Internal medicineCancerBioinformatics

Abstract

fetched live from OpenAlex

e11000 Background: Benefits of adjuvant chemotherapy for early-stage breast cancer patients (pts) depend on baseline recurrence risks. Gene expression profiling (GEP) of tumours informs baseline risk prediction, potentially reducing unnecessary treatment and healthcare costs. Limited evidence exists on its clinical utility; we explored pts and medical oncologists (MO) perspectives on GEP in chemotherapy decisions. Methods: We used a qualitative design of individual interviews with MO (n=10), focus groups and individual interviews with pts (n=20) from Ontario. Pts who underwent genomic testing of their tumours (‘OncotypeDx’), were recruited through clinics from two academic hospitals in Toronto. MO were recruited through clinics, advertisements and referrals from the research team. Data were analyzed using interpretative qualitative methods, including content analysis, qualitative description and constant comparison techniques. Results: Pts and MO valued GEP as an additional decision-support tool, complementing existing clinical indicators. Its perceived utility varied between pts and MO. Pts valued the test highly, suggesting it was one of the primary determinants of their treatment decision. All pts followed the course of action their results suggested. Pts with intermediate scores often used the results to reinforce their pre-existing treatment preferences. MO were mixed about the test’s utility. Some considered it another tool supporting their approach to risk assessments, while others used it more definitively to resolve their uncertainty. MO explained the test’s contribution to decision-making but remained uncertain about pts understanding and expectations of the test. Some raised concerns about the variability of its use and interpretation within their medical community. Conclusions: Pts and MO valued the test, often using it as a primary determinant in their treatment decision, despite MO concerns about its technical limitations and pts limited understanding. Results identify a need for informational decision aids and practice guidelines to support pts understanding and standardized application of the test.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.022
metaresearch head score (Gemma)0.036
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: Qualitative
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.022
Threshold uncertainty score0.114

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0220.036
Meta-epidemiology (narrow)0.0000.001
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0070.011
Scholarly communication0.0080.005
Open science0.0010.006
Research integrity0.0040.006
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.082
GPT teacher head0.436
Teacher spread0.354 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designQualitative
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2012
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicBRCA gene mutations in cancer→French-language works237,207→